⌘K

Login Start Free

Home/Filings/4/0001127602-23-018089

4//SEC Filing

PENDARVIS DAVID 4

Accession 0001127602-23-018089

CIK 0000943819other

View on SEC.gov Company Profile

Filed

Jun 6, 8:00 PM ET

Accepted

Jun 7, 12:20 PM ET

Size

4.6 KB

Accession

0001127602-23-018089

Insider Transaction Report

Form 4

Period: 2023-06-05

PENDARVIS DAVID

Sr. VP, General Counsel

Transactions

Sale
ResMed Common Stock
2023-06-05$219.79/sh−1,500$329,685→ 89,729 total

Footnotes (2)

[F1]The transaction was conducted under a Rule 10b5-1 plan adopted November 29, 2022.
[F2]Includes 56.7807 shares of ResMed stock purchased on April 28, 2023, through the ResMed Employee Stock Purchase Plan.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

RESMED INC

CIK 0000943819

Entity typeother

Related Parties

1

filerCIK 0001196723

Filing Metadata

Form type: 4
Filed: Jun 6, 8:00 PM ET
Accepted: Jun 7, 12:20 PM ET
Size: 4.6 KB

View on SEC.gov